These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36449257)

  • 21. Heme iron polypeptide for the management of anaemia of chronic kidney disease.
    Dull RB; Davis E
    J Clin Pharm Ther; 2015 Aug; 40(4):386-90. PubMed ID: 25953602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using a discrete choice experiment to elicit patients' preferences and willingness-to-pay for knee osteoarthritis treatments in Thailand.
    Luksameesate P; Tanavalee A; Ngorsuraches S; Taychakhoonavudh S
    Sci Rep; 2023 Jul; 13(1):12154. PubMed ID: 37500677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment.
    Janse S; Janssen E; Huwig T; Basu Roy U; Ferris A; Presley CJ; Bridges JFP
    Curr Med Res Opin; 2021 Apr; 37(4):643-653. PubMed ID: 33571024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis.
    Akizawa T; Yamaguchi Y; Otsuka T; Reusch M
    Nephron; 2020; 144(8):372-382. PubMed ID: 32580188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why does the treatment of anaemia not improve cardiac outcomes in CKD?
    Parfrey PS
    Nat Rev Nephrol; 2013 Jan; 9(1):59-61. PubMed ID: 23070577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis.
    Shepshelovich D; Rozen-Zvi B; Avni T; Gafter U; Gafter-Gvili A
    Am J Kidney Dis; 2016 Nov; 68(5):677-690. PubMed ID: 27321965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.
    Ossa DF; Briggs A; McIntosh E; Cowell W; Littlewood T; Sculpher M
    Pharmacoeconomics; 2007; 25(3):223-37. PubMed ID: 17335308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
    Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
    Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal anaemia treatment in haemodialysis patients in the Central and Eastern European countries in everyday clinical practice follow-up.
    Malyszko J; Drozdz M; Zolkiewicz A; Rutkowski B
    Int Urol Nephrol; 2014 Jan; 46(1):71-82. PubMed ID: 23136027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Doctor, can I have less frequent injection with highly efficient treatment?" A patient centered study using an electronic choice-based conjoint analysis (ePRO) to assess real world preferences regarding erythropoiesis stimulating agent to treat anaemia in chronic kidney disease (PERCEPOLIS study).
    Vigneau C; Choukroun G; Isnard-Bagnis C; Pau D; Sinnasse-Raymond G; Pibre S; Moranne O
    Nephrol Ther; 2019 Jun; 15(3):152-161. PubMed ID: 30962139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients' preferences for osteoporosis drug treatment: a discrete-choice experiment.
    Hiligsmann M; Dellaert BG; Dirksen CD; van der Weijden T; Goemaere S; Reginster JY; Watson V; Boonen A
    Arthritis Res Ther; 2014 Jan; 16(1):R36. PubMed ID: 24479410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.
    Oliveri S; Lanzoni L; Veldwijk J; de Wit GA; Petrocchi S; Janssens R; Schoefs E; Smith MY; Smith I; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Petrella F; Casiraghi M; Galli G; Garassino MC; Girvalaki C; Huys I; Pravettoni G
    Front Psychol; 2023; 14():1062830. PubMed ID: 37425173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment.
    Turk D; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Walsh D
    Osteoarthritis Cartilage; 2020 Sep; 28(9):1202-1213. PubMed ID: 32652238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment.
    Hiligsmann M; Dellaert BG; Dirksen CD; Watson V; Bours S; Goemaere S; Reginster JY; Roux C; McGowan B; Silke C; Whelan B; Diez-Perez A; Torres E; Papadakis G; Rizzoli R; Cooper C; Pearson G; Boonen A
    Rheumatology (Oxford); 2017 Jul; 56(7):1167-1176. PubMed ID: 28398547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenging patient phenotypes in the management of anaemia of chronic kidney disease.
    Pramod S; Goldfarb DS
    Int J Clin Pract; 2021 Nov; 75(11):e14681. PubMed ID: 34331826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale.
    Macdougall IC; Bock A; Carrera F; Eckardt KU; Gaillard C; Van Wyck D; Roubert B; Cushway T; Roger SD;
    Nephrol Dial Transplant; 2014 Apr; 29(4):843-50. PubMed ID: 24170814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Darbepoetin for the anaemia of chronic kidney disease.
    Palmer SC; Saglimbene V; Craig JC; Navaneethan SD; Strippoli GF
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD009297. PubMed ID: 24683046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents.
    Io H; Aizawa M; Funabiki K; Horikoshi S; Tomino Y
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():7-13. PubMed ID: 26439537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, incidence, and treatment of anaemia in patients with non-dialysis-dependent chronic kidney disease: findings from a retrospective real-world study in Italy.
    Minutolo R; Grandaliano G; Di Rienzo P; Snijder R; Degli Esposti L; Perrone V; Todorova L
    J Nephrol; 2023 Mar; 36(2):347-357. PubMed ID: 36370331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which Factors Are Considered by Patients When Considering Total Joint Arthroplasty? A Discrete-choice Experiment.
    Salimy MS; Humphrey TJ; Katakam A; Melnic CM; Heng M; Bedair HS
    Clin Orthop Relat Res; 2023 Mar; 481(3):427-437. PubMed ID: 36111881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.